The UW-Madison ‘One Health Center’ will advance the development and production of vaccines against emerging diseases.
View More Ella Foundation, US varsity to set up research center for new vaccines
Dr Ella said that Bharat Biotech’s nasal vaccine against Covid-19 will soon be available in hospital for inoculation.
View More Covaxin maker Dr Krishna Ella defends Brand India over drug quality
NEW DELHI: Bharat Biotech’s Covaxin has proven to be ‘safe, well-tolerated, and highly immunogenic’ in children in Phase II/III studies, the results of which are…
View More Covaxin Safe, Highly Immunogenic In Children, Says Study
NEW DELHI: Bharat Biotech International Limited confirms that COVAXIN successfully conducted the stage II/III study on children. The trials have proven to be safe, well…
View More ‘COVAXIN Shows Better Antibody Response In Children Aged Between 2-18 Years Than Adults’
Even as India celebrated the 100 Crore vaccine dose mark last week, Dr. Krishna Ella who is the founder of Bharat Biotech, maker of indegenious…
View More Medicos Laud India’s First Upcoming Nasal Vax; Admit Global R&D Still Required
NEW DELHI: In the part two of an extensive interview with The New Indian’s Executive Editor, Dr Krishna Ella of Bharat Biotech speaks on the…
View More We’re Producing 4-5 Cr Covaxin Doses Per Month, Plan To Ramp Up By 1.5 Cr: Bharat Biotech MD (Part 2)
NEW DELHI: In the very first interaction hours ahead of WHO permission to issue international certification, Dr Krishna Ella of Bharat Biotech shares with The…
View More Hurt By Bullying On COVAXIN Just Because PM Took It; We’re Just Scientists, Undeterred By Attack, Bringing India’s Nasal Vax Now: Bharat Biotech MD (Part 1)
